# CVS HEALTH CORPORATION (CVS) FY2025 Q1 Balance Sheet

- Company: CVS HEALTH CORPORATION (CVS)
- Period: As of 2025-03-31
- Filing: Q1 FY2025 10-Q, filed 2025-05-01, accession number 0000064803-25-000013
- Page: https://plicit.ai/financials/cvs/fy2025-q1-balance-sheet
- Chart image: https://plicit.ai/charts/cvs-fy2025-q1-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2025-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 255,585,000,000 US dollars
- **Current assets**: 73,191,000,000 US dollars
- **Non-current assets**: 182,394,000,000 US dollars
- **Liabilities**: 178,475,000,000 US dollars
- **Current liabilities**: 88,961,000,000 US dollars
- **Non-current liabilities**: 89,514,000,000 US dollars
- **Equity**: 77,110,000,000 US dollars
- **Noncontrolling interest**: 181,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Accounts receivable, net**: 39,625,000,000 US dollars
- **Inventories**: 17,385,000,000 US dollars
- **Cash and cash equivalents**: 10,076,000,000 US dollars
- **Other current assets**: 3,527,000,000 US dollars
- **Investments**: 2,578,000,000 US dollars
- **Goodwill**: 91,203,000,000 US dollars
- **Long-term investments**: 28,906,000,000 US dollars
- **Intangible assets, net**: 26,570,000,000 US dollars
- **Operating lease right-of-use assets**: 15,704,000,000 US dollars
- **Property and equipment, net**: 12,856,000,000 US dollars
- **Other assets**: 5,231,000,000 US dollars
- **Separate accounts assets**: 1,924,000,000 US dollars
- **Pharmacy claims and discounts payable**: 25,797,000,000 US dollars
- **Accrued expenses and other current liabilities**: 22,369,000,000 US dollars
- **Accounts payable**: 16,534,000,000 US dollars
- **Health care costs payable**: 15,112,000,000 US dollars
- **Current portion of long-term debt**: 4,411,000,000 US dollars
- **Current portion of operating lease liabilities**: 1,909,000,000 US dollars
- **Other insurance liabilities**: 1,570,000,000 US dollars
- **Short-term debt**: 1,259,000,000 US dollars
- **Long-term debt**: 59,040,000,000 US dollars
- **Long-term operating lease liabilities**: 14,594,000,000 US dollars
- **Other long-term liabilities**: 5,419,000,000 US dollars
- **Other long-term insurance liabilities**: 4,873,000,000 US dollars
- **Deferred income taxes**: 3,664,000,000 US dollars
- **Separate accounts liabilities**: 1,924,000,000 US dollars
- **Retained earnings**: 63,768,000,000 US dollars
- **Common stock, par value $0.01: 3,200 shares authorized; 1,779 shares issued and 1,262 shares outstanding at March 31, 2025 and 1,778 shares issued and 1,260 shares outstanding at December 31, 2024 and capital surplus**: 49,837,000,000 US dollars
- **Accumulated other comprehensive income (loss)**: 59,000,000 US dollars
- **Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding**: 0 US dollars
- **Noncontrolling interests**: 181,000,000 US dollars
- **Treasury stock, at cost: 517 shares at March 31, 2025 and 518 shares at December 31, 2024**: negative 36,735,000,000 US dollars
- **Gross equity (calculated)**: 113,845,000,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.